New research
Neuroeconomics and Adolescent Substance Abuse: Individual Differences in Neural Networks and Delay Discounting

https://doi.org/10.1016/j.jaac.2013.04.013Get rights and content

Objective

Many adolescents with substance use problems show poor response to evidence-based treatments. Treatment outcome has been associated with individual differences in impulsive decision making as reflected by delay discounting (DD) rates (preference for immediate rewards). Adolescents with higher rates of DD were expected to show greater neural activation in brain regions mediating impulsive/habitual behavioral choices and less activation in regions mediating reflective/executive behavioral choices.

Method

Thirty adolescents being treated for substance abuse completed a DD task optimized to balance choices of immediate versus delayed rewards, and a control condition accounted for activation during magnitude valuation. A group independent component analysis on functional magnetic resonance imaging time courses identified neural networks engaged during DD. Network activity was correlated with individual differences in discounting rate.

Results

Higher discounting rates were associated with diminished engagement of an executive attention control network involving the dorsolateral prefrontal cortex, dorsomedial prefrontal cortex, inferior parietal cortex, cingulate cortex, and precuneus. Higher discounting rates also were associated with less deactivation in a “bottom-up” reward valuation network involving the amygdala, hippocampus, insula, and ventromedial prefrontal cortex. These 2 networks were significantly negatively correlated.

Conclusions

Results support relations between competing executive and reward valuation neural networks and temporal decision making, an important, potentially modifiable risk factor relevant for the prevention and treatment of adolescent substance abuse.

Clinical trial registration information—The Neuroeconomics of Behavioral Therapies for Adolescent Substance Abuse, http://clinicaltrials.gov/, NCT01093898.

Section snippets

Neural Mechanisms of DD

A meta-analysis identified 25 regions of significant neural activation during DD tasks.9 Three primary regions of robust activation include value-related regions (ventral striatum), value consideration regions (medial prefrontal cortex [PFC]), and future forecasting regions (posterior cingulate cortex). These regions are consistent with the valuation network proposed by Peters and Buchel,10 who also proposed 2 additional networks important in DD: a cognitive control network, involving

Participants

Participants were recruited from 2 ongoing studies investigating behavioral treatments for adolescent substance abuse (marijuana trial and alcohol trial). Fifty-two subjects enrolled in the treatment studies during recruitment for the present study. Two teens refused screening and 9 screened eligible but declined to participate in this study. Six subjects were not eligible for MRI owing to metal in their body (most often braces), and 2 reported claustrophobia and were not scanned. In addition,

Pairwise Contrasts

Voxel-wise, brain-wide planned contrasts of SS-CON and LL-CON choices resulted in distributed neural activations typically attributed to impulsive and deliberative choice behavior. Task-related activations are reported in Table S3, Table S4, available online, and represent those that survived a cluster-level correction for multiple comparisons.

SS Versus CON

Compared with the judgment of relative monetary amount in the CON trials, the choice of SS rewards was associated with activation of the dorsomedial,

Discussion

Whole-brain pairwise contrasts indicated extensive activations broadly consistent with many other DD fMRI studies.9 Group ICA yielded 7 components reflecting theoretically consistent regions of neural coactivation during all trials. Activation in 2 components or networks showed significant relations with individual DD rates. However, neither effect survived the Bonferroni correction, supporting the need to replicate these findings. One network, a putative valuation network, showed ventral

References (42)

  • M. Field et al.

    Delay discounting and the alcohol Stroop in heavy drinking adolescents

    Addiction

    (2007)
  • J. Audrain-McGovern et al.

    Applying a behavioral economic framework to understanding adolescent smoking

    Psychol Addict Behav

    (2004)
  • J.H. Yoon et al.

    Delay discounting predicts postpartum relapse to cigarette smoking among pregnant women

    Exp Clin Psychopharmacol

    (2007)
  • Y. Washio et al.

    Delay discounting is associated with treatment response among cocaine-dependent outpatients

    Exp Clin Psychopharmacol

    (2011)
  • Krishnan-Sarin S, Reynolds B, Duhig AM et al. Behavioral impulsivity predicts treatment outcome in a smoking cessation...
  • C. Stanger et al.

    Delay discounting predicts treatment outcome among adolescent substance abusers

    Exp Clin Psychopharmacol

    (2012)
  • R. Carter et al.

    Functional neuroimaging of intertemporal choice models: a review

    J Neurosci Psychol Econ

    (2010)
  • S.J. Blakemore et al.

    Development of the adolescent brain: implications for executive function and social cognition

    J Child Psychol Psychiatry

    (2006)
  • J.N. Giedd et al.

    Brain development during childhood and adolescence: a longitudinal MRI study

    Nat Neurosci

    (1999)
  • N. Gogtay et al.

    Dynamic mapping of human cortical development during childhood through early adulthood

    Proc Natl Acad Sci U S A

    (2004)
  • L. Green et al.

    Discounting of delayed rewards: a life-span comparison

    Psychol Sci.

    (1994)
  • Cited by (62)

    • The neural basis underlying the relation between the action identification level and delay discounting: The medial and orbital frontal cortex functional connectivity with the precuneus

      2021, International Journal of Psychophysiology
      Citation Excerpt :

      Similar effect was found in pathological gamblers that the episodic tags could enhance the striatal valuation signals during temporal discounting (Wiehler et al., 2017). In parallel to these results, studies showed that imaging future events allowed for increasing value on the later-larger rewards, biasing the subsequent decisions towards choices with a higher long-term pay-off (Benoit et al., 2011; Stanger et al., 2013). Intriguingly, higher identification levels were characteristic of the disengagement from immediate context to act in the light of distal significance (Vallacher and Wegner, 1989).

    • The associations of comorbid substance use disorders and psychiatric conditions with adolescent brain structure and function: A review

      2020, Journal of the Neurological Sciences
      Citation Excerpt :

      In parallel, Stanger et al. [118], in their study on adolescents in treatment for AUD and marijuana use disorder (MUD), found participants with higher discounting rates had less deactivation throughout the reward network and less activation in more frontal areas than those with lower discounting rates [118]. While over one third of participants in this sample had comorbid ADHD, it is unclear how that diagnosis interacts with SUDs to affect neural response discounting rates [118]. However, another group found that adolescents with ADHD had lower activation in the right inferior frontal gyrus, dorsolateral PFC, anterior insula, dorsal striatum and bilateral cerebellum during the delayed discounting task, independent of discounting rates, relative to healthy comparisons [94].

    View all citing articles on Scopus

    This research was funded by National Institute on Drug Abuse grants DA029442, DA015186, and DA022981, by National Institute on Alcohol Abuse and Alcoholism grant AA016917, and by UL1TR000039 and KL2TR000063 through the NIH National Center for Research Resources and the National Center for Advancing Translational Sciences.

    Disclosure: Dr. Stanger has received support from the National Institutes of Health (NIH) and the Sturgis Foundation. Dr. Budney has received support from the NIH. Dr. Kilts has received support from the NIH and has attended a scientific advisory board meeting for Allergan and a national advisory board meeting for a mental health facility (Skyland Trail). He is a co-holder of U.S. patent 6,373,990 (“Method and Device for the Transdermal Delivery of Lithium”). Drs. Elton, James, and Ryan report no biomedical financial interests or potential conflicts of interest.

    View full text